https://orcid.org/0000-0002-4634-6491
References
- Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pr. 2010;87(3):302–312. doi:10.1016/j.diabres.2010.01.024
- Health Promotion Administration. Ministry of Health and Welfare. Statistics of Health Promotion; 2018 Available from: http: Users/user/Downloads/Statistics+of+Health+Promotion+2018%20(1).pdf.
- Joseph B, Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013;3(2):93–102. doi:10.1016/S2222-1808(13)60052-3
- Lo HY, Ho TY, Lin C, Li CC, Hsiang CY. Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor. J Agric Food Chem. 2013;61:2461–2468. doi:10.1021/jf304240223414136
- Lo HY, Ho TY, Li CC, Chen JC, Liu JJ, Hsiang CY. A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway. J Agric Food Chem. 2014;62:8952–8961. doi:10.1021/jf500209925144709
- Lo HY, Li CC, Ho TY, Hsiang CY. Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein. Food Chem. 2016;204:298–305. doi:10.1016/j.foodchem.2016.02.13526988505
- Garau C, Cummings EF, Phoenix DA, Singh J. Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review. Int J Diabetes Metab. 2003;11:46–55.
- Bhushan MS, Rao CHV, Ojha SK, et al. An analytical review of plants for anti-diabetic activity with their phyto constituent and mechanism of action. Int J Pharm Sci Res. 2010;1:29–46.
- Hsu PK, Pan FF, Hsieh CS. mcIRBP-19 of bitter melon peptide effectively regulates diabetes mellitus (DM) patients’ blood sugar levels. Nutrients. 2020;12(5):1252. doi:10.3390/nu12051252
- Carpenter CJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Commun. 2010;25(8):661–669. doi:10.1080/10410236.2010.52190621153982
- Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676–1685.8487827
- Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215. doi:10.1037/0033-295X.84.2.191847061
- Rosenstock IM, Strecher VJ, Becker M. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–183. doi:10.1177/1090198188015002033378902
- Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47. doi:10.1177/1090198184011001016392204
- Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complicat. 2012;26(1):10–16. doi:10.1016/j.jdiacomp.2011.11.002
- Chih AH, Jan CF, Shu SG et al. Self-efficacy affects blood sugar control among adolescents with type I diabetes mellitus. J Formos Med Assoc. 2010;109(7):503–510.20654789
- Peters GJY, Ruiter RA, Kok G. Threatening communication: a critical re-analysis and a revised meta-analytic test of fear appeal theory. Health Psycho Rev. 2013;7:S8–S31. doi:10.1080/17437199.2012.703527
- El-Toukhy S. Parsing susceptibility and severity dimensions of health risk perceptions. J Health Commun. 2015;20(5):499–511. doi:10.1080/10810730.2014.98934225749555
- Seyde E, Taal E, Wiegman O. Risk-appraisal, outcome and self-efficacy expectancies: cognitive factors in preventive behaviour related to cancer. Psycho Health. 1990;4:99–109. doi:10.1080/08870449008408144
- Lin K, Park C, Li M, et al. Effects of depression, diabetes distress, diabetes self-efficacy, and diabetes self-management on glycemic control among Chinese population with type 2 diabetes mellitus. Diabetes Res Clin Pr. 2017;131:179–186. doi:10.1016/j.diabres.2017.03.013